CRBP CORBUS PHARMACEUTICA

8.85
+0.55  (6.63%)
Previous Close 8.30
Open 8.40
Price To book 27.39
Market Cap 393.27M
Shares 44,437,000
Volume 1,959,227
Short Ratio 8.86
Av. Daily Volume 772,102

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data due 1Q 2017.
Resunab
Cystic Fibrosis
Phase 2 trial to be initiated 1H 2017.
Resunab
Systemic lupus erythematosus (SLE)
Phase 2 data due 3Q 2017.
Resunab
Dermatomyositis
Phase 2 data released November 14, 2016.
Resunab
Systemic Sclerosis

Latest News

  1. This Marijuana Stock Was Up 412% in 2016. Will the Run Continue?
  2. Corbus Pharmaceuticals to Host Research and Development Day on March 13, 2017
  3. Three Biotechs With Bullish Basing Patterns
  4. Top 5 States for Marijuana Stocks
  5. Marijuana Stocks: What to Watch in 2017
  6. Corbus Pharmaceuticals Holdings, Inc. – Value Analysis (NASDAQ:CRBP) : January 18, 2017
  7. ETFs with exposure to Corbus Pharmaceuticals Holdings, Inc. : January 17, 2017
  8. Why Corbus Pharmaceuticals Holdings, Inc. Stock Rocketed 412% Upwards in 2016
  9. Corbus Pharmaceuticals Receives Orphan Designation for JBT-101 for the Treatment of Systemic Sclerosis in the European Union
  10. Donald Trump On Weed Legalization: What’s In Store For Marijuana Stocks?
  11. The 10 Best Stocks in the Nasdaq in 2016
  12. Here's How Big the Opportunity Could Be for Marijuana Stocks
  13. Corbus Pharmaceuticals Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CRBP-US : January 13, 2017
  14. ETFs with exposure to Corbus Pharmaceuticals Holdings, Inc. : January 4, 2017
  15. Corbus Concludes Phase II study of Cystic Fibrosis Candidate
  16. Corbus Pharmaceuticals Announces Completion of Phase 2 Study of JBT-101 (Resunab) for the Treatment of Cystic Fibrosis
  17. Corbus Pharmaceuticals Looks to Be a Winner, While Pershing Gold Requires Patience
  18. Here Are 4 Somewhat Risky Stocks That May Deliver Explosive Gains
  19. ETFs with exposure to Corbus Pharmaceuticals Holdings, Inc. : December 21, 2016
  20. As Dow heads to 20,000, here are the 20 top-gaining Mass. stocks this year